Market Study on the High Content Screening Market: The Market is Driven by Rapidly Evolving Technological Capabilities in Healthcare Industry

The High Content Screening Market report presents the global High Content Screening sales and revenue by companies, regions, type and application and forecast to 2027. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Get Sample Report Here

Overview

In biological science and drug development, HCS (high-content screening) is used to find substances like peptides, small molecules, or RNAi which change the cell’s phenotype as required. HCS systems find application in any level of drug development. Metabolism, cell sorting, absorption, selectivity, and permeability are all examples of this.

The global high content screening (HCS) market is projected to surpass US$ 2,387.9 million by the end of 2027, from a valuation of US$ 1,404.6 million in 2018.

Drivers

During the forecast period, R&D in drug exploration is expected to drive growth of the global high content screening (HCS) market. Purdue University researchers assessed the impact of IL-27 – a heterodimeric cytokine made up of the subunits IL-27p28 and EBI3 (Epstein–Barr virus-induced gene 3) – on gene expression variations in TC2R prostate adenocarcinoma cells in February 2020.

Furthermore, increased investment in HCS is expected to fuel growth of the global high content screening (HCS) market. St. Jude Children’s Research Hospital spent US$ 13.4 million in January 2020 to build a laboratory resource centre that will feature two additional laboratories, the Center for Modeling Human Pediatric Diseases and High Content Screening.

In terms of value, North America dominated the global high content screening (HCS) market in 2018, contributing about 36.4 percent of the market share, led by Europe.

Restraints

Image analysis for HCS is a labor-intensive and time-consuming method, which is expected to stifle market development.

Furthermore, developing economies’ lack of budget for high-end HCS instruments is projected to stifle growth of the global high content screening (HCS) market.

The global high content screening (HCS) market’s cell imaging and analysis equipment segment was worth US$ 550.1 million in 2018, and is projected to grow at a CAGR of 5.8% to US$ 911.3 million by 2027.

Market Trends

AI (Artificial Intelligence) is being used in HCS, according to the market. In a HCS, automation allows for the fast identification of all cellular phenotypes. It will also cut down on the time and money spent on phenotypic image processing. Olympus released the scanR HCS station in December 2019, a cell imaging solution that uses AI to allow next-generation biological research.

The HCS software is being used to build an integrated imaging pipeline. In a zebrafish model for human cystic kidney disease, researchers from Digital Biomedical Imaging Systems AG recorded processing and analysing HCS datasets in March 2019 using custom-developed heuristic algorithms incorporated in standard open-source image analysis tools to classify chemical modifiers of glomerular cyst formation.

Key Developments

The key players in the market are concentrating on introducing new products in order to extend their product range. At the SLAS2020 International Conference and Exhibition in California in January 2020, PerkinElmer, Inc. unveiled new workstations and the Opera Phenix Plus High Content Screening System.

To broaden their product range, key market players are focusing on cooperation and alliance initiatives. GE Healthcare Life Sciences and Advanced Solutions Life Sciences announced a strategic R&D and delivery collaboration in December 2019 under which BioAssemblyBot will be combined with the IN Cell Analyzer 6500 HS confocal screening tool to automate HCS in 3D models for customised tissue regeneration.

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3487

High Content Screening Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation, and Thorlabs, Inc.

Main points in High Content Screening Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global High Content Screening Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: High Content Screening Industry Impact

Chapter 2 Global High Content Screening Competition by Types, Applications, and Top Regions and Countries
2.1 Global High Content Screening (Volume and Value) by Type
2.3 Global High Content Screening (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global High Content Screening Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America High Content Screening Market Analysis
Chapter 6 East Asia High Content Screening Market Analysis
Chapter 7 Europe High Content Screening Market Analysis
Chapter 8 South Asia High Content Screening Market Analysis
Chapter 9 Southeast Asia High Content Screening Market Analysis
Chapter 10 Middle East High Content Screening Market Analysis
Chapter 11 Africa High Content Screening Market Analysis
Chapter 12 Oceania High Content Screening Market Analysis
Chapter 13 South America High Content Screening Market Analysis
Chapter 14 Company Profiles and Key Figures in High Content Screening Business
Chapter 15 Global High Content Screening Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com